UK: Cost Budgeting In A Living Mesothelioma Case

Last Updated: 12 September 2019
Article by Will Potts, Thomas Jordan and Christopher Gower

Whilst mostly of academic interest rather than of broader practical relevance, an interesting case management decision was made by Master Thornett in a living mesothelioma claim by ordering that the claim be subject to cost budgeting.

It is usual for cost budgeting to be dispensed within the asbestos list, for the obvious reason that in mesothelioma claims the court is dealing with dying or recently bereaved claimants, with living claims being particularly time sensitive. The lack of cost budgeting frees up the Masters' list to offer short notice CMCs under the show cause procedure to either resolve the issue of liability or to set down prompt directions to trial. However, certain cases can involve significant, expensive, expert evidence and it was for this reason that the potential for cost budgeting arose.

The claim involved a living mesothelioma sufferer who was undergoing private immunotherapy and who also advanced a substantial claim for the future private care of his disabled wife. It was claimed he would have provided for his wife but for his death due to mesothelioma.

The claimant was permitted to rely on expert evidence from a respiratory surgeon, consultant oncologist, a care expert, and a further report in respect of the life expectancy of the claimant and his wife. The defendants were granted permission to rely on their own expert care evidence as well as life expectancy evidence.

In light of the significant expert evidence and trial time estimate of 3 days, the Master ordered the claimant to provide an estimate of cost and thereafter the defendants had the opportunity to request a budgeting hearing. The claimant chose to serve the estimate of costs, in the form of a Precedent H costs budget, totalling around £230,000.00 with future costs being approximately £135,000.00. The defendants duly requested a budgeting hearing. The parties exchanged budgets with the claimant serving 2 further budgets which increased his overall costs to over £260,000.00. Precedent Rs were exchanged but a day before the hearing it was confirmed that the claimant's position would be that any cost budgeting would be opposed.

The claimant argued that such cases were unsuitable for cost budgeting saying they are wildly unpredictable.  It was submitted that the lack of cost budgeting did not mean the claimant has a free hand in incurring costs as detailed assessment would still take place at the end of the action. The claimant's position was that cost budgeting would increase satellite litigation in the list and that in this case the majority of costs had already been incurred.

Master Thornett was not convinced and ordered that cost budgeting take place, but highlighted that it was not to be intended to be prescriptive generally in the asbestos list. The Master held that whilst the convention was to not cost budget, those engaged in asbestos list are not immune from proportionality of costs. Whilst it may well be that the overwhelming percentage of cases have no suggestion of costs management, the usual protocol is that the issue is expressly canvassed at every CMC even if the order to dispense with cost budgeting usually goes through "on the nod".

The Master pointed out that in catastrophic PI and high value medical negligence cases there is often a degree of uncertainty about prognosis and these are routinely budgeted.  If matters arise outside of the predicted path there can also be variation to the cost budgets. Flexibility is regularly required and this was nothing that should challenge experienced solicitors. The fact that 3 different cost budgets were filed all within the space of weeks begged the question as to whether strategizing of litigation and costs was under control and the assertion that the majority of costs had been incurred was not born out in the cost budgets.

This was an unusual case and a better prepared claimant would likely have better prospects of opposing cost budgeting. The Master was not particularly impressed but the claimant's solicitors raising the objection very close to the hearing and the increasing cost budgets by the claimant served within a short period did them no favours.

When dealing with claims in the asbestos list, it is often presumed that the claim is not going to be budgeted. With advances in treatment options for victims of mesothelioma showing some success in prolonging life and function, it may be that fewer claimants will be seeking 1 day assessments as soon as possible with the need to preserve the position in relation to the funding of future treatment likely to take priority over a quick determination of the claim.

That being said, it is universally accepted that it is vital that there is capacity within the Masters' list for short notice hearings to be arranged in living mesothelioma cases. As both claimants and defendants negotiate the until-recently unchartered waters of agreeing suitable agreements for the funding of uncertain private treatment, this also creates the potential for the need for short notice hearings. Cost budgeting on a more regular basis could obviously impact this. However, the Masters also deal with less time sensitive asbestos injury claims such as diffuse pleural thickening and asbestosis. These cases are rarely time sensitive in the same way as living mesothelioma cases and could arguably be dealt with in the County Courts or District Registries, where cost budgeting could take place. Currently there seems to be little judicial appetite for such changes with the Masters usually unwilling to reallocate such cases out of the RCJ and it is understood that the updated practice direction is expected to explicitly cover all asbestos related injuries.

This case is however another example of costs inflation on mesothelioma claims which quite exceeds the additional damages paid for immunotherapy treatments. Cost budgeting is perhaps one way of monitoring this and challenging unnecessary costs on cases where on many occasions defendant lawyers and insurers are keen to agree funding for reasonably incurred treatment. The eventual outcome of the budgeting exercise was that the claimant's future costs were reduced by around £70,000.00, effectively cut in half.

Our Disease team deal with a number of mesothelioma and asbestos related claims on a regular basis. For more information, please get in touch.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Similar Articles
Relevancy Powered by MondaqAI
4 New Square Chambers
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
4 New Square Chambers
Related Articles
 
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions